The tablets are being recalled because of the presence or potential presence of N-nitrosodimethylamine (NDMA) levels above the acceptable daily intake levels established by the United States Food and Drug Administration (USFDA), as per the company's announcement posted on the website of the US health regulator.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2EF0w1h
via IFTTT
0 comments:
Post a Comment